The Latest Research, Commentary, And News From Health Affairs
Tuesday, August 10, 2021
Dear John,
Health Affairs’ continued leadership in the field of health policy is validated by its recent increase in Journal Impact Factor score to 6.301 for 2020, up almost a full point from 2019. This places Health Affairs in the top tier of journals in two categories: Health Policy and Services, and Health Care Sciences and Services.
COVID-19 And Social Determinants Of Health
For an article in the August issue, Sarah Miller and coauthors explored the influence of socioeconomic status, occupation, race, and ethnicity on COVID-19 mortality rates during the beginning
of the pandemic.
They observed increases in mortality rates for COVID-19 among populations in group-living situations such as correctional facilities or health care–related group quarters. They also observed increases in mortality rates among those without health insurance, with family incomes at or below the federal poverty level, and with occupations having few work-from-home options.
Further,
across almost all socioeconomic groups, they found that non-Hispanic Black people experienced significantly higher increases in mortality relative to non-Hispanic White people.
“Black people in the highest income group experienced an increase of mortality more than 3.5 times larger than the increase in mortality experienced by the poorest White people,” they report.
Today on Health Affairs Blog, Elizabeth Cope and coauthors discuss how to increase the numbers and diversity of research participants by
returning value to participants and incorporating digital tools to sustainably maximize impact and scale of these efforts.
Also, Liam Bendicksen and Christopher Koller argue that state policy makers should allow federal and state antitrust authorities to enjoin mergers they deem anticompetitive.
And Katie Keith covers today's announcement from Vice President Harris that more than2.5 million people enrolled in Marketplace coverage through HealthCare.gov and state-based Marketplaces
during the Biden administration's six-month broad COVID-19 special enrollment period.
James Robinson On The Drug Market, Innovation, Biosimilars, and What The French Get Right
Health Affairs Editor-in-Chief Alan Weil interviews James Robinson from the University of California Berkeley, School of Public Health on drug innovation, biosimilars, and market competition in the United States and beyond.
Health Affairs is the leading peer-reviewedjournalat the intersection of health, health care, and policy. Published
monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
